Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 7, 2009, Pages 469-475

  Grassi, G ^a   Seravalle, G ^a   Dell'Oro, R ^a   Arenare, F ^a   Facchetti, R ^a   Mancia, G ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Muscle sympathetic nerve traffic; Obesity; Plasma norepinephrine; Sympathetic activity

Indexed keywords

NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD SAMPLING; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INNERVATION; MALE; MICROELECTRODE; OBESITY; PATHOPHYSIOLOGY; PERONEUS NERVE; PHYSIOLOGY; REPRODUCIBILITY; SKELETAL MUSCLE; SYMPATHETIC NERVE;

ADULT; BLOOD PRESSURE; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEART RATE; HUMANS; MALE; MICROELECTRODES; MUSCLE, SKELETAL; NOREPINEPHRINE; OBESITY; PERONEAL NERVE; REPRODUCIBILITY OF RESULTS; SYMPATHETIC FIBERS, POSTGANGLIONIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 67651065839     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.09.008     Document Type: Article

References (30)

1. Scherrer U., Randin D., Tappy L., Vollenweider P., Jequier E., and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89 (1994) 2634-2640
2. Grassi G., Seravalle G., Cattaneo B.M., Bolla G.B., Lanfranchi A., Colombo M., et al. Sympathetic activation in obese normotensive subjects. Hypertension 25 (1995) 560-563
3. Vaz M., Jennings G., Turner A., Cox H., Lambert G., and Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96 (1997) 3423-3429
4. Narkiewicz K., van de Borne P.J., Cooley R.L., Dyken M.E., and Somers V.K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 (1998) 772-776
5. Rumantir M.S., Vaz M., Jennings G.L., Collier G., Kaye D.M., Seals D.R., et al. Neural mechanisms in human obesity-related hypertension. J Hypertens 17 (1999) 1125-1133
6. Grassi G., Seravalle G., Dell'Oro R., Turri C., Bolla G.B., and Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36 (2000) 538-542
7. Alvarez G.E., Beske S.D., Ballard T.P., and Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 106 (2002) 2533-2536
8. Grassi G., Facchini A., Quarti Trevano F., Dell'Oro R., Arenare F., Tana F., et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46 (2005) 321-325
9. Lambert E., Straznicky N., Schlaich M., Esler M., Dawood T., Hotchkin E., et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 50 (2007) 862-868
10. Grassi G., Quarti-Trevano F., Seravalle G., and Dell'Oro R. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr Metab Cardiovasc Dis 17 (2007) 473-481
11. Young J.B., and MacDonald I.A. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 16 (1992) 959-967
12. Esler M.D., Jennings G., Lambert G., Meredith I., Home M., and Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 70 (1990) 963-985
13. Esler M., Lambert G., Brunner-La Rocca H.P., Vaddadi G., and Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 177 (2003) 275-284
14. Grassi G., Bolla G., Seravalle G., Turri C., Lanfranchi A., and Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Lond) 92 (1997) 285-289
15. Seravalle G., Bolla G.B., Turri C., Stella M.L., Magnoni M., Grassi G., et al. Effects of multiple sampling on plasma norepinephrine reproducibility. J Hypertens 17 (1999) S45
16. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. European Society of Hypertension (ESH)/ European Society of Cardiology (ESC) 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 25 (2007) 1105-1187
17. Groppelli A., Omboni S., Parati G., and Mancia G. Evaluation of non-invasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intraarterial blood pressure. Hypertension 20 (1992) 227-232
18. Grassi G., Seravalle G., Cattaneo B.M., Lanfranchi A., Vailati S., Giannattasio C., et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92 (1995) 3206-3211
19. Hjemdahl P., Daleskong M., and Kanan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 25 (1979) 131-138
20. Goldstein D.S., Feuerstein G.Z., Izzo J.L., Kopin I.J., and Keiser H.R. Validity and reability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 28 (1981) 467-475
21. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
22. Grassi G., and Esler M. How to assess sympathetic activity in humans. J Hypertens 17 (1999) 719-734
23. Grassi G. Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. J Hypertens 19 (2001) 1713-1716
24. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19 (2001) 523-528
25. Grassi G. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens Rep 6 (2004) 236-240
26. Schlaich M.P., Lambert E., Kaye D.M., Krozowski Z., Campbell D.J., Lambert G., et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43 (2004) 169-175
27. Grassi G., Vailati S., Bertinieri G., Seravalle G., Stella M.L., Dell'Oro R., et al. Heart rate as marker of sympathetic activity. J Hypertens 16 (1998) 1635-1639
28. Waradekar N.V., Sinoway L.I., Zwillich C.W., and Leuenberger U.A. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153 (1996) 1333-1338
29. Imadojemu V.A., Mawji Z., Kunselman A., Gray K.S., Hogeman C.S., and Leuenberger U.A. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 131 (2007) 1406-1413
30. Wolf J., Lewicka J., and Narkiewicz K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis 17 (2007) 233-240